At Inizio Advisory, the combined intelligence of actionable data, powered by our data platform InizioNavigator.ai, and human expertise across our four businesses Research Partnership, Putnam, Vynamic and STEM underpins our unique ability to help you navigate your commercialization journey with confidence, by focusing on the question you want to answer, to help you to make the best decisions, faster.
Plan for success.
Be certain you’re heading in the right direction. Access expert pharma and biopharma strategic consultants utilizing AI in market research to deliver quality insights from our ecosystem of sources.
Lead strategy with certainty.
Allow our pharmaceutical experts to lead you down an innovative road to strategic excellence, where decision is led by data, insight and experience. Find out more.
Turn strategic guidance into action.
We deliver an optimal experience from team members to patients. We have an ability to synthesize data and insight at speed and transform with impact.
Make course corrections.
With a knowledge of what good looks like from our network of sources and projects, we can analyze and optimize. Our consultants’ depth of life science and healthcare sector knowledge keeps your strategy on track.
A data platform that combines human expertise and AI-driven insights, so our consultants can support you with faster strategic decision making when bringing your drugs to market.
It powers novel tools designed to aid our consulting teams unlock the value of artificial intelligence, data mining & analysis, helping you make confident decisions. So, whether you need help to prioritize assets for your product portfolios, or prioritize indications for your assets, our suite of InizioNavigator.ai tools, powered by our people, helps you find your way.
Using the power of AI and machine learning to help prioritize pipeline assets.
Smart decisions: Enables real-time strategic decision making, with the ability to rapidly refresh data in the future
Visual Insights: Summarized view of data in strategic charts (market, disease, biomarker, asset, trial-level, etc.)
Comparative Scores: Comprehensive scoring across various scientific, regulatory and commercial attributes
AI & ML Models: Trained machine learning and artificial intelligence models add ability to predict and interpret key insights from trial data such as anticipated time to market, patient-type categorization, expected line of therapy, and other results
Deeper insights. Faster: Real time access to pre-structured / merged data from 10+ sources providing instant access to deeper insights, at the touch of a button
Instant Filtering: Ability to instantly distil and restructure information or present multiple assets on a prioritized basis.
Using GenAI to assess insights and demonstrate impact.
Enables review of large volumes of structured and unstructured data from multiple sources.
Identification of validated themes that can be used based on brand needs.
Development of custom frameworks and dashboards to identify key insight themes, gaps, implications, medical actions, and impact metrics.
Using our proprietary data platform to help a top global biopharma integrate and analyze large amounts of data from multiple sources.
Let us help you find your way.
